A metagenome-wide association study of gut microbiota in type 2 diabetes, Nature, vol.490, issue.7418, pp.55-60, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01204262
A core gut microbiome in obese and lean twins, Nature, vol.457, issue.7228, p.2677729, 2009. ,
Obesity alters gut microbial ecology, Proc Natl Acad Sci, vol.102, issue.31, pp.11070-11075, 2005. ,
Richness of human gut microbiome correlates with metabolic markers, Nature, vol.500, issue.7464, pp.541-547, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01190602
Dietary intervention impact on gut microbial gene richness, Nature, vol.500, issue.7464, pp.585-593, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01001543
Major microbiota dysbiosis in severe obesity: fate after bariatric surgery, Gut, vol.68, issue.1, pp.70-82, 2019. ,
Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models, Gut, vol.59, issue.12, pp.1635-1677, 2010. ,
Faecalibacterium prausnitzii phylotypes in type two diabetic, obese, and lean control subjects, Beneficial microbes, vol.7, issue.4, pp.511-518, 2016. ,
Linking long-term dietary patterns with gut microbial enterotypes, Science, vol.334, issue.6052, p.3368382, 2011. ,
Microbial ecology: human gut microbes associated with obesity, Nature, vol.444, issue.7122, pp.1022-1025, 2006. ,
Molecular characterisation of the faecal microbiota in patients with type II diabetes, Curr Microbiol, vol.61, issue.1, pp.69-78, 2010. ,
Gut microbiota of obese, type 2 diabetic individuals is enriched in Faecalibacterium prausnitzii, Akkermansia muciniphila and Peptostreptococcus anaerobius after weight loss. Endocrine, metabolic & immune disorders drug targets, 2016. ,
Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers, Diabetes, vol.59, issue.12, pp.3049-57, 2010. ,
, , p.2992765
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability, Gut, vol.58, issue.8, pp.1091-103, 2009. ,
, , p.2702831
Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice, Diabetes, vol.60, issue.11, p.3198091, 2011. ,
Microbiome of prebiotictreated mice reveals novel targets involved in host response during obesity, ISME J, vol.8, issue.10, p.4163056, 2014. ,
A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice, Nat Med, vol.23, issue.1, pp.107-120, 2017. ,
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology, Gut, vol.65, issue.3, pp.426-462, 2016. ,
The gut microbiota as an environmental factor that regulates fat storage, Proc Natl Acad Sci U S A, vol.101, issue.44, p.524219, 2004. ,
Diabetes, obesity and gut microbiota, Best Pract Res Clin Gastroenterol, vol.27, issue.1, pp.73-83, 2013. ,
Microbiota and diabetes: an evolving relationship, Gut, vol.63, issue.9, pp.1513-1534, 2014. ,
Functional interactions between the gut microbiota and host metabolism, Nature, vol.489, issue.7415, pp.242-251, 2012. ,
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition, Cell Metab, vol.26, issue.4, pp.611-620, 2017. ,
Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome, Gastroenterology, vol.143, issue.4, pp.913-919, 2012. ,
Transplantation in diabetic kidney failure patients: modalities, outcomes, and clinical management, Semin Dial, vol.23, issue.2, pp.198-205, 2010. ,
New-onset diabetes mellitus after kidney transplantation: Current status and future directions, World J Diabetes, vol.6, issue.3, p.4398901, 2015. ,
Novel views on new-onset diabetes after transplantation: development, prevention and treatment, Nephrol Dial Transplant, vol.28, issue.3, p.4375396, 2013. ,
Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: prevention and treatment, Transplantation reviews, vol.28, issue.2, pp.37-46, 2014. ,
Population-based assessment of adverse events associated with long-term glucocorticoid use, Arthritis and rheumatism, vol.55, issue.3, pp.420-426, 2006. ,
Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction, J Am Soc Nephrol, vol.13, issue.1, pp.221-228, 2002. ,
Sirolimus is associated with new-onset diabetes in kidney transplant recipients, J Am Soc Nephrol, vol.19, issue.7, p.2440303, 2008. ,
The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease, Kidney Int, vol.83, issue.6, pp.1010-1016, 2013. ,
Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats, Nephrol Dial Transpl, vol.31, issue.3, pp.401-413, 2016. ,
Immunosuppressive Treatment Alters Secretion of Ileal Antimicrobial Peptides and Gut Microbiota, and Favors Subsequent Colonization by Uropathogenic Escherichia coli, Transplantation, vol.101, issue.1, pp.74-82, 2017. ,
, Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes, Diabetes Care, vol.41, issue.1, pp.13-27, 2018.
Fecal microbiota analysis: an overview of sample collection methods and sequencing strategies, Future Microbiol, vol.10, issue.9, pp.1485-504, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01535321
Human gut microbiota changes reveal the progression of glucose intolerance, PLoS One, vol.8, issue.8, p.3754967, 2013. ,
Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes, Genome Med, vol.8, issue.1, p.4756455, 2016. ,
The influence of gut microbiota on drug metabolism and toxicity. Expert opinion on drug metabolism & toxicology, vol.12, pp.31-40, 2016. ,
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug, Nat Med, vol.23, issue.7, pp.850-858, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01608413